Analab India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.17 M
- Company Age 43 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.60 M
About Analab India
Analab India Pvt Ltd (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 May 1981 and has a history of 43 years and eight months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.17 M.
The company has closed loans amounting to ₹3.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kaustav Mukherjee, Barid Mukherjee, and Sarmistha Mukherjee serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74210WB1981PTC033702
-
Company No.
033702
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 May 1981
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Analab India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Barid Mukherjee
|
Managing Director | 26-May-1981 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kaustav Mukherjee
|
Director | 17-Feb-2024 | Current |
|
Sarmistha Mukherjee
|
Director | 26-May-1981 | Current |
Financial Performance of Analab India.
Analab India Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Analab India?
In 2017, Analab India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹3.60 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.36 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2014 | State Bank Of India | ₹3.00 M | Satisfied |
| 09 Feb 2013 | State Bank Of India | ₹0.60 M | Satisfied |
How Many Employees Work at Analab India?
Unlock and access historical data on people associated with Analab India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Analab India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Analab India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.